Cargando…
Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury
Oxaliplatin is a core chemotherapeutic agent used for the treatment of colorectal liver metastasis; however, liver injury caused by oxaliplatin increases the risk of peri-operative morbidity and mortality. Magnesium isoglycyrrhizinate (MgiG) is a magnesium salt of 18-α glycyrrhizic acid stereo-isome...
Autores principales: | Zou, Xueqing, Wang, Yongmei, Peng, Cheng, Wang, Ben, Niu, Zhengchuan, Li, Zequn, Niu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108852/ https://www.ncbi.nlm.nih.gov/pubmed/30066834 http://dx.doi.org/10.3892/ijmm.2018.3787 |
Ejemplares similares
-
Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury
por: Jiang, Wenjiao, et al.
Publicado: (2017) -
Exploration of the hepatoprotective effect and mechanism of magnesium isoglycyrrhizinate in mice with arsenic trioxide-induced acute liver injury
por: Liu, Miaomiao, et al.
Publicado: (2021) -
Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy
por: Fan, Zihao, et al.
Publicado: (2022) -
Protective Effect of Magnesium Isoglycyrrhizinate on Ethanol-Induced Testicular Injuries in Mice
por: He, Yuanqiao, et al.
Publicado: (2010) -
Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities
por: Lu, Li, et al.
Publicado: (2021)